LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...

(RTTNews) - Shares of medical technology firm AngioDynamics, Inc. (ANGO) are rising more than 8% in pre-market on Wednesday after the company said on Tuesday that the FDA granted Breakthrough Device ...

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, ...

AngioDynamics (NASDAQ:ANGO) said that it has received breakthrough device designation from the FDA for its AngioVac System for the non-surgical removal of vegetation from the right heart. The ...

ALBANY, N.Y., AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announce the enrollment ...

Experts are now able to save patients from potentially fatal outcomes from blood clots, infected masses or foreign bodies from major cardiac blood vessels without performing open-heart surgery. The ...

AngioDynamics, a provider of minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is to acquire all the outstanding capital stock of Vortex ...

Lush vegetation is great for a gardener, but alarming for a cardiologist. For them, the news that Angiodynamics Inc. received U.S. FDA breakthrough device designation for its Angiovac system to remove ...

Normally, when you suffer from a pulmonary embolism—a blood clot blocking the flow to your lungs or heart—you’ve only have two options; undergo chest-cracking open-heart surgery, or die. But thanks to ...